about
Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibition.New similarity-based algorithm and its application to classification of anticonvulsant compounds.Computer-Aided Identification of Anticonvulsant Effect of Natural Nonnutritive Sweeteners Stevioside and Rebaudioside AMulti-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective.Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates.The new patient and responsible self-medication practices: a critical review.CNS drug development - lost in translation?An integrated drug development approach applying topological descriptors.Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules).Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).Is there a relationship between sweet taste and seizures? Anticonvulsant and proconvulsant effects of non-nutritive sweeteners.High-throughput drug repositioning for the discovery of new treatments for Chagas disease.Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design Stage.The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough.Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.Computational approaches for innovative antiepileptic drug discovery.Hybrid Compounds as Anti-infective Agents.Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in rats.Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action.Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.Systematic Comparison of the Performance of Different 2D and 3D Ligand-Based Virtual Screening Methodologies to Discover Anticonvulsant Drugs.Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir.Prediction of drug intestinal absorption by new linear and non-linear QSPR.A successful virtual screening application: prediction of anticonvulsant activity in MES test of widely used pharmaceutical and food preservatives methylparaben and propylparaben.Anticonvulsant effect of sodium cyclamate and propylparaben on pentylenetetrazol-induced seizures in zebrafish.Anticonvulsant activity of artificial sweeteners: a structural link between sweet-taste receptor T1R3 and brain glutamate receptors.New QSPR study for the prediction of aqueous solubility of drug-like compounds.Discovery of anticonvulsant activity of abietic acid through application of linear discriminant analysis.The application of molecular topology for ulcerative colitis drug discovery.Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.Computer-Aided Drug Design: An Overview.Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening.Tailored Multi-Target Agents. Applications and Design Considerations.Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake.Identification of levothyroxine antichagasic activity through computer-aided drug repurposingInteraction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon ResonanceApplication of Computer-Aided Drug Repurposing in the Search of New Cruzipain Inhibitors: Discovery of Amiodarone and Bromocriptine Inhibitory Effects
P50
Q33259931-C0AA82D7-0283-4167-8AF8-ACCAB02D9E80Q33293008-40EDA483-1C3D-40F9-8A71-A1C1A2F5DACAQ35942551-E1FD6AFD-5E48-4BB9-B3EA-6D5FECE1586CQ36097620-E35D99C4-F182-419B-94B4-20E409F9B1F2Q37105057-B71C7EB0-FE0B-4D41-93C8-9ADA678FB509Q37771047-20F2BD26-4A3B-4F33-898F-5B12106E8709Q37993906-51DA1DB5-2974-48D7-AEDB-5F35E5B910EAQ38021822-48D8D6D4-76B4-492C-9031-5F26062695C9Q38066250-1FF85CAD-3AB1-46CB-BF97-DD5B02C11FC4Q38098272-25C25C54-7E98-43E7-8A45-F1EC8909E5A9Q38369432-BDB3EDB5-E68C-4A3A-9214-248CAAB5F741Q38377145-C37301AC-6A0B-44D5-89CC-EA4633601998Q38679117-FE73DE6C-E345-422D-86A4-B7EF71F07F01Q38735517-ADE64676-0244-424E-973F-5EB4C323F617Q38735529-42E0D07A-EC1B-413A-BF66-D557B18B912FQ38907478-E22EBC0C-768E-49BE-8323-11A0068B81C3Q38970850-DB954BAF-3B6A-4731-8AC9-6F8C07D3117DQ38973485-64E7C828-4884-4386-A04C-B1F9C0E7287AQ38980218-00066707-D970-420C-A40E-C62390EBAFDCQ40078146-9A30E00D-B4D1-484F-8563-0D54AE1143A1Q40662799-6163261F-D32B-4633-9568-D7B03737705FQ40785976-87CF967A-22F5-46CF-9BD0-6039C6AAB36BQ41278052-92FE24CE-216E-4A38-81C0-B8D7E7749FD0Q41468933-9CDB7082-0365-4551-BC91-7FC6BD194DEDQ43921052-648D6245-C638-4B00-9CE3-A4140390A4C5Q46932252-D054E76C-803D-4A4D-9F1D-531351F58412Q48316817-24004653-5C4B-4D4D-AA46-3048AD4E8277Q48517474-A0FF38CC-7ED2-4FFF-A263-39E4D48512CCQ51871292-0ECB08E1-ED82-4446-A82F-47D9BA708CD1Q51925022-20FA27A5-FEC8-4B4C-B62E-3578C3687EF2Q52448502-ED3B0E5E-7AE6-4BFF-B0FC-A89E31681AA8Q52600766-F84D963B-B3C6-42A1-9265-C575EC205CA0Q52623662-E8AFA729-B185-4A2A-A4AC-AD6D1230EFD9Q52679396-E8B9CF9A-200F-4B70-8124-C8940E055981Q53794192-AB4D73D0-0D83-4D00-B346-8BEA0F5307D9Q54217459-9FE3FA82-070D-45BD-B0C1-E322705AAE44Q55401605-BC1B60A0-910B-46F7-BF44-B94D42153820Q59075291-450940F7-9339-4016-B0B1-B7EA941C966BQ59146736-398EF8C5-A284-4865-A6D0-001DE585ED37Q62128103-9520F4C7-306D-40C1-8312-CC886228665F
P50
description
Argentijns onderzoeker
@nl
Argentine pharmacist
@en
farmacéutico argentino
@es
pharmacien argentin
@fr
pharmacist Argentine
@en-ca
pharmacist Argentine
@en-gb
հետազոտող
@hy
صيدلي أرجنتيني
@ar
name
Alan Talevi
@ast
Alan Talevi
@en
Alan Talevi
@es
Alan Talevi
@fr
Alan Talevi
@nl
Alan Talevi
@sl
type
label
Alan Talevi
@ast
Alan Talevi
@en
Alan Talevi
@es
Alan Talevi
@fr
Alan Talevi
@nl
Alan Talevi
@sl
altLabel
A Talevi
@en
A Talevi
@es
A Talevi
@fr
prefLabel
Alan Talevi
@ast
Alan Talevi
@en
Alan Talevi
@es
Alan Talevi
@fr
Alan Talevi
@nl
Alan Talevi
@sl
P103
P106
P1153
14833640500
P1412
P1559
Alan Talevi
@es
P19
P1960
TqFfWCsAAAAJ
P2038
Alan_Talevi
P21
P214
6075148997650259870002
P2456
P27
P2798
P31
P3946
P496
0000-0003-3178-826X
P569
1980-01-01T00:00:00Z
P6634
alan-talevi-8073571a